MGA271 from BOC Sciences

Supplier Page

Supplier Page from
BOC Sciences for
MGA271

Description

Enoblituzumab is a monoclonal antibody designed for the treatment of cancer. Formerly known as MGA271, the drug is a humanized IgG1κ monoclonal antibody recognizing human. B7-H3, a member of the B7 family of immune regulators